Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Primary immunodeficiency diseases in a tuberculosis endemic region: challenges and opportunities.

Glanzmann B, Uren C, de Villiers N, van Coller A, Glashoff RH, Urban M, Hoal EG, Esser MM, Möller M, Kinnear CJ.

Genes Immun. 2018 Sep 6. doi: 10.1038/s41435-018-0041-0. [Epub ahead of print]

PMID:
30185814
2.

Autosomal Dominant IFN-γR1 Deficiency Presenting with both Atypical Mycobacteriosis and Tuberculosis in a BCG-Vaccinated South African Patient.

Glanzmann B, Möller M, Moncada-Velez M, Peter J, Urban M, van Helden PD, Hoal EG, de Villiers N, Glashoff RH, Nortje R, Bustamante J, Abel L, Casanova JL, Boisson-Dupuis S, Esser M, Kinnear CJ.

J Clin Immunol. 2018 May;38(4):460-463. doi: 10.1007/s10875-018-0509-8. Epub 2018 May 18. No abstract available.

PMID:
29777412
3.

HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa.

Maponga TG, Andersson MI, van Rensburg CJ, Arends JE, Taljaard J, Preiser W, Glashoff RH.

BMC Infect Dis. 2018 May 8;18(1):214. doi: 10.1186/s12879-018-3115-8.

4.

Clinical Relevance of Total HIV DNA in Peripheral Blood Mononuclear Cell Compartments as a Biomarker of HIV-Associated Neurocognitive Disorders (HAND).

Ruhanya V, Jacobs GB, Glashoff RH, Engelbrecht S.

Viruses. 2017 Oct 31;9(11). pii: E324. doi: 10.3390/v9110324. Review.

5.

Patterns of prevalent HPV and STI co-infections and associated factors among HIV-negative young Western Cape, South African women: the EVRI trial.

Menezes LJ, Pokharel U, Sudenga SL, Botha MH, Zeier M, Abrahamsen ME, Glashoff RH, Engelbrecht S, Schim van der Loeff MF, van der Laan LE, Kipping S, Taylor D, Giuliano AR.

Sex Transm Infect. 2018 Feb;94(1):55-61. doi: 10.1136/sextrans-2016-053046. Epub 2017 May 10.

PMID:
28490581
6.

HPV SEROSTATUS PRE- AND POST-VACCINATION IN A RANDOMIZED PHASE II PREPAREDNESS TRIAL AMONG YOUNG WESTERN CAPE, SOUTH AFRICAN WOMEN: THE EVRI TRIAL.

Sudenga SL, Torres BN, Botha MH, Zeier M, Abrahamsen ME, Glashoff RH, Engelbrecht S, Schim Van der Loeff MF, Van der Laan LE, Kipping S, Taylor D, Giuliano AR.

Papillomavirus Res. 2017 Jun;3:50-56. doi: 10.1016/j.pvr.2017.02.001. Epub 2017 Feb 16.

7.

Mammalian cell cultures as models for Mycobacterium tuberculosis-human immunodeficiency virus (HIV) interaction studies: A review.

Chingwaru W, Glashoff RH, Vidmar J, Kapewangolo P, Sampson SL.

Asian Pac J Trop Med. 2016 Sep;9(9):832-838. doi: 10.1016/j.apjtm.2016.07.002. Epub 2016 Jul 26. Review.

8.

Cervical HPV natural history among young Western Cape, South African women: The randomized control EVRI Trial.

Sudenga SL, Torres BN, Botha MH, Zeier M, Abrahamsen ME, Glashoff RH, Engelbrecht S, Schim Van der Loeff MF, Van der Laan LE, Kipping S, Taylor D, Giuliano AR.

J Infect. 2016 Jan;72(1):60-9. doi: 10.1016/j.jinf.2015.10.001. Epub 2015 Oct 19.

9.

High HIV, HPV, and STI prevalence among young Western Cape, South African women: EVRI HIV prevention preparedness trial.

Giuliano AR, Botha MH, Zeier M, Abrahamsen ME, Glashoff RH, van der Laan LE, Papenfuss M, Engelbrecht S, Schim van der Loeff MF, Sudenga SL, Torres BN, Kipping S, Taylor D.

J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):227-35. doi: 10.1097/QAI.0000000000000425. Erratum in: J Acquir Immune Defic Syndr. 2015 Oct 1;70(2):e72.

10.

Role of inflammation in HIV-1 disease progression and prognosis.

Ipp H, Zemlin AE, Erasmus RT, Glashoff RH.

Crit Rev Clin Lab Sci. 2014 Apr;51(2):98-111. doi: 10.3109/10408363.2013.865702. Epub 2014 Jan 30. Review.

PMID:
24479745
11.

CD4+ T cells in HIV infection show increased levels of expression of a receptor for vasoactive intestinal peptide, VPAC2.

Ipp H, Nkambule BB, Reid TD, de Swardt D, Bekker LG, Glashoff RH.

Immunol Res. 2014 Oct;60(1):11-5. doi: 10.1007/s12026-014-8487-2.

PMID:
24469917
12.

Complex patterns of genomic admixture within southern Africa.

Petersen DC, Libiger O, Tindall EA, Hardie RA, Hannick LI, Glashoff RH, Mukerji M; Indian Genome Variation Consortium, Fernandez P, Haacke W, Schork NJ, Hayes VM.

PLoS Genet. 2013;9(3):e1003309. doi: 10.1371/journal.pgen.1003309. Epub 2013 Mar 14.

13.
14.

Serum adenosine deaminase and total immunoglobulin G correlate with markers of immune activation and inversely with CD4 counts in asymptomatic, treatment-naive HIV infection.

Ipp H, Zemlin AE, Glashoff RH, van Wyk J, Vanker N, Reid T, Bekker LG.

J Clin Immunol. 2013 Apr;33(3):605-12. doi: 10.1007/s10875-012-9832-7. Epub 2012 Nov 16.

PMID:
23160984
15.

A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses.

Malnati MS, Heltai S, Cosma A, Reitmeir P, Allgayer S, Glashoff RH, Liebrich W, Vardas E, Imami N, Westrop S, Nozza S, Tambussi G, Buttò S, Fanales-Belasio E, Ensoli B, Ensoli F, Tripiciano A, Fortis C, Lusso P, Poli G, Erfle V, Holmes H.

J Immunol Methods. 2012 Jan 31;375(1-2):46-56. doi: 10.1016/j.jim.2011.09.005. Epub 2011 Sep 22.

PMID:
21963950
16.

Functional integrity of naturally occurring mutants of HIV-1 subtype C Vpr.

Romani B, Glashoff RH, Engelbrecht S.

Virus Res. 2010 Nov;153(2):288-98. doi: 10.1016/j.virusres.2010.08.020. Epub 2010 Aug 27.

PMID:
20801175
17.

Genetic structure of a unique admixed population: implications for medical research.

Patterson N, Petersen DC, van der Ross RE, Sudoyo H, Glashoff RH, Marzuki S, Reich D, Hayes VM.

Hum Mol Genet. 2010 Feb 1;19(3):411-9. doi: 10.1093/hmg/ddp505. Epub 2009 Nov 5.

PMID:
19892779
18.

Functions of Tat: the versatile protein of human immunodeficiency virus type 1.

Romani B, Engelbrecht S, Glashoff RH.

J Gen Virol. 2010 Jan;91(Pt 1):1-12. doi: 10.1099/vir.0.016303-0. Epub 2009 Oct 7. Review.

PMID:
19812265
19.

Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif.

Romani B, Engelbrecht S, Glashoff RH.

Arch Virol. 2009;154(10):1579-88. doi: 10.1007/s00705-009-0481-y. Epub 2009 Aug 12. Review.

PMID:
19669862
20.

Risk for HIV-1 infection associated with a common CXCL12 (SDF1) polymorphism and CXCR4 variation in an African population.

Petersen DC, Glashoff RH, Shrestha S, Bergeron J, Laten A, Gold B, van Rensburg EJ, Dean M, Hayes VM.

J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):521-6.

Supplemental Content

Loading ...
Support Center